Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $4.27 in the prior trading day, GoodRx Holdings Inc (NASDAQ: GDRX) closed at $4.24, down -0.70%. In other words, the price has decreased by -$0.70 from its previous closing price. On the day, 1.36 million shares were traded. GDRX stock price reached its highest trading level at $4.26 during the session, while it also had its lowest trading level at $4.11.
Ratios:
Our goal is to gain a better understanding of GDRX by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.81 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 10.53. For the most recent quarter (mrq), Quick Ratio is recorded 5.48 and its Current Ratio is at 5.48. In the meantime, Its Debt-to-Equity ratio is 0.78 whereas as Long-Term Debt/Eq ratio is at 0.77.
On May 23, 2024, RBC Capital Mkts Upgraded its rating to Outperform which previously was Sector Perform and also upped its target price recommendation from $8 to $10.
Raymond James Upgraded its Mkt Perform to Outperform on May 16, 2024, while the target price for the stock was maintained at $10.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 03 ’24 when Spectrum Equity VII, L.P. sold 10,677 shares for $7.86 per share. The transaction valued at 83,922 led to the insider holds 0 shares of the business.
Spectrum VII Investment Manage bought 6,828 shares of GDRX for $53,668 on Sep 03 ’24. On Sep 03 ’24, another insider, Spectrum VII Co-Investment Fun, who serves as the Affiliate of the company, bought 3,849 shares for $7.86 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GDRX now has a Market Capitalization of 1616042112 and an Enterprise Value of 1741968128. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.04 while its Price-to-Book (P/B) ratio in mrq is 2.32. Its current Enterprise Value per Revenue stands at 2.204 whereas that against EBITDA is 16.338.
Stock Price History:
Over the past 52 weeks, GDRX has reached a high of $9.26, while it has fallen to a 52-week low of $4.09. The 50-Day Moving Average of the stock is -33.88%, while the 200-Day Moving Average is calculated to be -41.28%.
Shares Statistics:
The stock has traded on average 1.35M shares per day over the past 3-months and 3052440 shares per day over the last 10 days, according to various share statistics. A total of 92.36M shares are outstanding, with a floating share count of 85.81M. Insiders hold about 77.49% of the company’s shares, while institutions hold 17.96% stake in the company. Shares short for GDRX as of 1730332800 were 8691418 with a Short Ratio of 6.44, compared to 1727654400 on 9031629. Therefore, it implies a Short% of Shares Outstanding of 8691418 and a Short% of Float of 9.3100004.
Earnings Estimates
The current rating of GoodRx Holdings Inc (GDRX) reflects the combined expertise of 13.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is $0.1, with high estimates of $0.11 and low estimates of $0.09.
Analysts are recommending an EPS of between $0.4 and $0.33 for the fiscal current year, implying an average EPS of $0.34. EPS for the following year is $0.41, with 14.0 analysts recommending between $0.47 and $0.35.
Revenue Estimates
14 analysts predict $200.23M in revenue for the current quarter. It ranges from a high estimate of $207M to a low estimate of $199.09M. As of the current estimate, GoodRx Holdings Inc’s year-ago sales were $196.64MFor the next quarter, 14 analysts are estimating revenue of $203.59M. There is a high estimate of $207.35M for the next quarter, whereas the lowest estimate is $197.8M.
A total of 16 analysts have provided revenue estimates for GDRX’s current fiscal year. The highest revenue estimate was $801M, while the lowest revenue estimate was $792.83M, resulting in an average revenue estimate of $793.99M. In the same quarter a year ago, actual revenue was $760.26MBased on 16 analysts’ estimates, the company’s revenue will be $829.47M in the next fiscal year. The high estimate is $874.83M and the low estimate is $813.76M.
